TY  - GEN 
AU  - Mangia, A.
AU  - Milligan, S.
AU  - Khalili, M.
AU  - Fagiuoli, S.
AU  - Shafran, S. D.
AU  - Carrat, F.
AU  - Ouzan, D.
AU  - Papatheodoridis, G.
AU  - Ramji, A.
AU  - Borgia, S. M.
AU  - Wedemeyer, H.
AU  - Losappio, R.
AU  - Perez-Hernandez, F.
AU  - Wick, N.
AU  - Brown, R. S.
AU  - Lampertico, P.
AU  - Doucette, K.
AU  - Ntalla, I.
AU  - Ramroth, H.
AU  - Mertens, M.
AU  - Vanstraelen, K.
AU  - Turnes Vázquez, Juan
PY  - 2020
SN  - 1478-3223
UR  - http://hdl.handle.net/20.500.11940/16360
AB  - BACKGROUND AND AIMS: Achieving sustained virological response (SVR; cure) in hepatitis C patients using a simple regimen is key to making elimination by 2030 possible. In the largest real-world analysis to date, the effectiveness of pangenotypic,...
KW  - Heterocyclic Compounds
KW  - Drug Therapy
KW  - Adult
KW  - Humans
KW  - Treatment Outcome
KW  - Ribavirin
KW  - Hepacivirus
KW  - Genotype
KW  - Carbamates
KW  - Antiviral Agents
TI  - Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts
DO  - 10.1111/liv.14537
KW  - CHUP
VL  - 40
ER  -